These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 35392743)

  • 1. The Impact of an Electronic Health Record Intervention on Spirometry Completion in Patients with Chronic Obstructive Pulmonary Disease.
    Wang C; Siff J; Greco PJ; Warren E; Thornton JD; Tarabichi Y
    COPD; 2022; 19(1):142-148. PubMed ID: 35392743
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Accuracy of electronic health record data for the diagnosis of chronic obstructive pulmonary disease in persons living with HIV and uninfected persons.
    Crothers K; Rodriguez CV; Nance RM; Akgun K; Shahrir S; Kim J; W Soo Hoo G; Sharafkhaneh A; Crane HM; Justice AC
    Pharmacoepidemiol Drug Saf; 2019 Feb; 28(2):140-147. PubMed ID: 29923258
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical Implications of Bronchodilator Testing: Diagnosing and Differentiating COPD and Asthma-COPD Overlap.
    Annangi S; Coz-Yataco AO
    Respir Care; 2022 Apr; 67(4):440-447. PubMed ID: 35338095
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Estimating the U.S. prevalence of chronic obstructive pulmonary disease using pre- and post-bronchodilator spirometry: the National Health and Nutrition Examination Survey (NHANES) 2007-2010.
    Tilert T; Dillon C; Paulose-Ram R; Hnizdo E; Doney B
    Respir Res; 2013 Oct; 14(1):103. PubMed ID: 24107140
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnosis and management of stable chronic obstructive pulmonary disease: a clinical practice guideline update from the American College of Physicians, American College of Chest Physicians, American Thoracic Society, and European Respiratory Society.
    Qaseem A; Wilt TJ; Weinberger SE; Hanania NA; Criner G; van der Molen T; Marciniuk DD; Denberg T; Schünemann H; Wedzicha W; MacDonald R; Shekelle P; ; ; ;
    Ann Intern Med; 2011 Aug; 155(3):179-91. PubMed ID: 21810710
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Point of Care Portable Spirometry in the Diagnosis and Treatment of Inpatients with Chronic Obstructive Pulmonary Disease.
    Tran D; Lim M; Vogrin S; Jayaram L
    Lung; 2020 Feb; 198(1):143-150. PubMed ID: 31894409
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of primary-care spirometry on the diagnosis and management of COPD.
    Walker PP; Mitchell P; Diamantea F; Warburton CJ; Davies L
    Eur Respir J; 2006 Nov; 28(5):945-52. PubMed ID: 16870668
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development and validation of the Salzburg COPD-screening questionnaire (SCSQ): a questionnaire development and validation study.
    Weiss G; Steinacher I; Lamprecht B; Kaiser B; Mikes R; Sator L; Hartl S; Wagner H; Studnicka M
    NPJ Prim Care Respir Med; 2017 Jan; 27(1):4. PubMed ID: 28127061
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Perseverant, non-indicated treatment of obese patients for obstructive lung disease.
    Fortis S; Kittah J; De Aguirre M; Plataki M; Wolff A; Amoateng-Adjepong Y; Manthous CA
    BMC Pulm Med; 2013 Nov; 13():68. PubMed ID: 24266961
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Management of COPD in the UK primary-care setting: an analysis of real-life prescribing patterns.
    Price D; West D; Brusselle G; Gruffydd-Jones K; Jones R; Miravitlles M; Rossi A; Hutton C; Ashton VL; Stewart R; Bichel K
    Int J Chron Obstruct Pulmon Dis; 2014; 9():889-904. PubMed ID: 25210450
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Determinants of initial inhaled corticosteroid use in patients with GOLD A/B COPD: a retrospective study of UK general practice.
    Chalmers JD; Tebboth A; Gayle A; Ternouth A; Ramscar N
    NPJ Prim Care Respir Med; 2017 Jun; 27(1):43. PubMed ID: 28663549
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Accuracy of diagnostic registers and management of chronic obstructive pulmonary disease: the Devon primary care audit.
    Jones RC; Dickson-Spillmann M; Mather MJ; Marks D; Shackell BS
    Respir Res; 2008 Aug; 9(1):62. PubMed ID: 18710575
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reversible Airflow Obstruction Predicts Future Chronic Obstructive Pulmonary Disease Development in the SPIROMICS Cohort: An Observational Cohort Study.
    Buhr RG; Barjaktarevic IZ; Quibrera PM; Bateman LA; Bleecker ER; Couper DJ; Curtis JL; Dolezal BA; Han MK; Hansel NN; Krishnan JA; Martinez FJ; McKleroy W; Paine R; Rennard SI; Tashkin DP; Woodruff PG; Kanner RE; Cooper CB;
    Am J Respir Crit Care Med; 2022 Sep; 206(5):554-562. PubMed ID: 35549640
    [No Abstract]   [Full Text] [Related]  

  • 14. Pharmacist-Driven Spirometry Screening to Target High-Risk Patients in a Primary Care Setting.
    Whitner JB; Mueller LA; Valentino AS
    J Prim Care Community Health; 2019; 10():2150132719889715. PubMed ID: 31771404
    [No Abstract]   [Full Text] [Related]  

  • 15. The association of weight with the detection of airflow obstruction and inhaled treatment among patients with a clinical diagnosis of COPD.
    Collins BF; Ramenofsky D; Au DH; Ma J; Uman JE; Feemster LC
    Chest; 2014 Dec; 146(6):1513-1520. PubMed ID: 24763942
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Persistent Empiric COPD Diagnosis and Treatment After Pulmonary Function Test Showed No Obstruction.
    Fortis S; Corazalla EO; Jacobs DR; Kim HJ
    Respir Care; 2016 Sep; 61(9):1192-200. PubMed ID: 27165420
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adherence to current guidelines for chronic obstructive pulmonary disease (COPD) among patients treated with combination of long-acting bronchodilators or inhaled corticosteroids.
    Asche CV; Leader S; Plauschinat C; Raparla S; Yan M; Ye X; Young D
    Int J Chron Obstruct Pulmon Dis; 2012; 7():201-9. PubMed ID: 22500120
    [TBL] [Abstract][Full Text] [Related]  

  • 18. COPD-X Australian and New Zealand guidelines for the diagnosis and management of chronic obstructive pulmonary disease: 2017 update.
    Yang IA; Brown JL; George J; Jenkins S; McDonald CF; McDonald VM; Phillips K; Smith BJ; Zwar NA; Dabscheck E
    Med J Aust; 2017 Nov; 207(10):436-442. PubMed ID: 29129177
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Respiratory pharmacotherapy use in patients newly diagnosed with chronic obstructive pulmonary disease in a primary care setting in the UK: a retrospective cohort study.
    Wurst KE; Shukla A; Muellerova H; Davis KJ
    COPD; 2014 Sep; 11(5):521-30. PubMed ID: 24945236
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Indacaterol therapy in moderate-to-severe chronic obstructive pulmonary disease: findings from a single-center primary care cohort.
    Singh MP
    Int J Chron Obstruct Pulmon Dis; 2013; 8():613-9. PubMed ID: 24353411
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.